Reye’s Syndrome & Teens

Talk to your teens and understand the risk of Reye’s Syndrome.

The growing issue of self-medication among teens is serious and alarming. Emails and calls from
parents and school nurses highlight the increasing risks, especially when teens take medications
like aspirin or products containing salicylates. One mother shared her concern in an urgent
message:
“My 12-year-old took Excedrin Extra Strength last night, which contains 250 mg of aspirin per
pill for a headache. I’ve never kept aspirin at home because of Reye’s Syndrome, but my husband
had Excedrin in his truck.”
Many teens mistakenly believe that misusing prescription or over-the-counter medications is
safer than abusing illegal drugs. In fact, 41% of teens think medication abuse is less dangerous,
and most say it's easier to get prescription drugs than illegal substances.

Item content. Click the edit button to change this text.

Item content. Click the edit button to change this text.

Item content. Click the edit button to change this text.

Item content. Click the edit button to change this text.

The National Reye’s Syndrome Foundation is a registered 501(c)(3) nonprofit organization dedicated to public education on health risks associated with aspirin use, including its link to Reye’s Syndrome. The information provided on our website, publications, and outreach materials is for educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before making any medical decisions regarding aspirin or other medications. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The National Reye’s Syndrome Foundation does not endorse nor promote any specific treatments, products, or pharmaceutical companies.
For any medical concerns, please seek guidance from a licensed healthcare provider.

National Reye’s Syndrome Foundation426 North Lewis StreetP.O. Box 829Bryan, OH 43506

Subscribe to Newsletter

You have been successfully Subscribed! Ops! Something went wrong, please try again.

Developed by Lassiter Advertising

Privacy Policy | User Policy | Terms & Condition